Highlights
A collection of news and information related to Merck & Company Incorporated published by this site and its partners.
Displaying items 1-12 of 572
» View courant.com items only
1
2
3
4
5
6
7
8
9
10
11-48
•
Next >
-
Boy Scouts of America votes to end century-old ban on gay scouts
ReutersGRAPEVINE, Texas (Reuters) - The Boy Scouts of America voted on Thursday to lift a century-old ban on openly gay scouts in a major victory for gay rights activists, but the decision means a sea of change for an organization that depends heavily on faith-...Tags: Intel Corp., Youth Organizations, UPS Inc., Social Organizations, Lifestyle and Leisure
-
UCF trustees approve $1.4 billion operating budget that includes no tuition increase
Sentinel School ZoneTrustees at the University of Central Florida this afternoon approved a $1.4 billion operating budget for the coming school year that includes no tuition increase. But Chief Financial Officer Bill Merck explained that base undergraduate tuition for...Tags: Budgets and Budgeting, Colleges and Universities, Education, Rick Scott, University of Central Florida
-
Merck halts development of experimental Parkinson's drug
ReutersMay 23 (Reuters) - Merck & Co has ended development of preladenant, an experimental drug for Parkinson's disease, after initial data from three late-stage trials proved disappointing. New Jersey-based Merck said the decision to discontinue the studies...Tags: Medical Research, Science and Technology, Parkinson's Disease, Diseases and Illnesses
-
RPT-FEATURE-Pfizer takes its shot at a vaccine for evasive superbug
ReutersBy Julie Steenhuysen CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year...Tags: Iron (dietary supplement), HPV Vaccine, Health and Safety at School, Disease Prevention, Politics
-
EUROPE RESEARCH ROUNDUP: ARM Holdings, Anglo American, Statoil, Bayer
ReutersMay 23 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Anglo American, Bayer and Thomas Cook Group, on Thursday. HIGHLIGHTS * ARM Holdings PLC : Exane BNP Paribas cuts to neutral from...Tags: Softball, Morgan Stanley Dean Witter & Company, HSBC Holdings plc, UBS AG, Sports
-
FDA panel: Merck's insomnia drug effective, safe at low doses
ReutersWASHINGTON, May 22 (Reuters) - Merck & Co's experimental insomnia drug is safe and effective at the lower of two doses studied but not at the higher, a panel of medical experts said on Wednesday. The panel, which advises the U.S. Food and Drug...Tags: Insomnia, Food and Drug Administration
-
Merck's insomnia drug moves a step closer to U.S. approval
ReutersWASHINGTON (Reuters) - Merck & Co's experimental insomnia drug moved a step closer to U.S. approval on Wednesday after a panel of medical experts said it is effective and safe at lower doses. The advisory panel was convened to help the U.S. Food and Drug...Tags: Car Safety Tips and Advice, Ambien (drug), Insomnia, Politics, Drugs and Medicines
-
Indian stocks to watch-May 23
ReutersMay 23 (Reuters) - GLOBAL MARKETS ROUNDUP * Nifty futures on the Singapore Exchange are 0.5 percent down and the MSCI-Asia Pacific index excluding Japan is 1.5 percent lower. * Japanese government bond prices dived and 10-year JGB futures tumbled a full...Tags: Patents, Copyrights and Trademarks, Federal Reserve, Finance, Tokyo Stock Exchange, S&P 500
-
FDA panel backs a new sleep drug
An advisory panel to the Food & Drug Administration has recommended approval of a new sleep drug that targets the brain's wakefulness centers, but suggested the agency should consider a dose of the drug, called suvorexant, lower than that proposed by...
Tags: Insomnia, Politics, Pharmaceuticals, Food and Drug Administration, Chemical Industry
-
Merck anuncia acuerdo de recompra acciones por 5.000 mln dlrs con Goldman Sachs
Reuters21 mayo (Reuters) - Merck & Co Inc dijo que entró en un acuerdo de recompra de acciones por 5.000 millones de dólares con Goldman Sachs Group Inc, en momentos en que el gigante farmacéutico busca apuntalar el valor de los accionistas frente a la dura...Tags: Goldman Sachs Group, Inc.
-
Immune system cancer drugs tipped to be a $35 bln market
Reuters* Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines...Tags: Amgen Inc., HIV, Oncology, Weather Reports, Medical Research
-
Immune system cancer drugs tipped to be a $35 billion market
ReutersLONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year. That bullish sales forecast by analysts at U.S. bank...Tags: Amgen Inc., HIV, Oncology, Medical Research, Weather Reports
May 23, 2013
|Story| Reuters
May 23, 2013
| Orlando Sentinel
May 23, 2013
|Story| Reuters
May 23, 2013
|Story| Reuters
May 23, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Los Angeles Times
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
Original site for Merck & Company Incorporated topic gallery.
